A broadly cross-protective monoclonal antibody binding to Escherichia coli and Salmonella lipopolysaccharides.
During the last decade, episodes of sepsis have increased and Escherichia coli has remained the most frequent clinical isolate. Lipopolysaccharides (LPS; endotoxin) are the major toxic and antigenic components of gram-negative bacteria and qualify as targets for therapeutic interventions. Molecules...
Kaydedildi:
| Yayımlandı: | Infect Immun |
|---|---|
| Asıl Yazarlar: | , , , , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
American Society for Microbiology (ASM)
1993
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC281087/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8359907/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/iai.61.9.3863-3872.1993 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|